Literature DB >> 10488226

Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy.

H Pelloux1, H Fricker-Hidalgo, G Brochier, A Goullier-Fleuret, P Ambroise-Thomas.   

Abstract

The serological diagnosis of toxoplasmic infection during pregnancy is intended to prevent congenital infection of the fetus. However, in the context of recurrent pregnancy loss intravenous immunoglobulin therapy can create a biological trap for the interpretation of serological results, with potentially serious consequences for the outcome of the pregnancy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10488226      PMCID： PMC85593          DOI： 10.1128/JCM.37.10.3423-3424.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  [Interference of polyvalent immunoglobulins in toxoplasmosis serology].

Authors:  B Fortier; F Ajana; A S Valat; M C Bouchez
Journal:  Ann Biol Clin (Paris)       Date:  1992       Impact factor: 0.459

2.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

3.  Evaluation of the second generation IMx Toxo IgG antibody assay for detection of antibodies to Toxoplasma gondii in human sera.

Authors:  C De Champs; H Pelloux; M Cambon; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis.

Authors:  O Liesenfeld; C Press; R Flanders; R Ramirez; J S Remington
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 5.  Toxoplasmosis in pregnancy.

Authors:  S Y Wong; J S Remington
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

6.  Spurious serologic test results in patients receiving infusions of intravenous immune gammaglobulin.

Authors:  B Lichtiger; K Rogge
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

7.  The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities.

Authors:  D D Kiprov; R D Nachtigall; R C Weaver; A Jacobson; E K Main; M R Garovoy
Journal:  Am J Reprod Immunol       Date:  1996-10       Impact factor: 3.886

8.  Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid.

Authors:  P Hohlfeld; F Daffos; J M Costa; P Thulliez; F Forestier; M Vidaud
Journal:  N Engl J Med       Date:  1994-09-15       Impact factor: 91.245
  8 in total
  6 in total

1.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

Review 2.  ASO titer or not? When to use streptococcal serology: a guide for clinicians.

Authors:  T Parks; P R Smeesters; N Curtis; A C Steer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

3.  Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune Globulin.

Authors:  Neil M Vora; Lillian A Orciari; J Bradford Bertumen; Inger Damon; James A Ellison; Vance G Fowler; Richard Franka; Brett W Petersen; P S Satheshkumar; Stephen M Schexnayder; Todd G Smith; Ryan M Wallace; Susan Weinstein; Carl Williams; Pamela Yager; Michael Niezgoda
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-02-09       Impact factor: 17.586

4.  Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.

Authors:  Hiroyuki Takamatsu; Shinya Yamada; Noriaki Tsuji; Noriharu Nakagawa; Erika Matsuura; Atsuo Kasada; Keijiro Sato; Kohei Hosokawa; Noriko Iwaki; Masahisa Arahata; Hidenori Tanaka; Shinji Nakao
Journal:  Transplant Direct       Date:  2021-05-18

5.  Misleading Positive Serology for Cat Scratch Disease following Administration of Intravenous Immunoglobulin.

Authors:  Michal Yakubovsky; Yoav Golan; Alex Guri; Itzhak Levy; Daniel Glikman; Moshe Ephros; Michael Giladi
Journal:  Pathogens       Date:  2022-01-27

6.  Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.

Authors:  Simon Parker; Eliza Gil; Patricia Hewitt; Katherine Ward; Yasmin Reyal; Sasha Wilson; Jessica Manson
Journal:  BMC Infect Dis       Date:  2014-02-22       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.